We now offer acute blood genetic tests to prevent and manage any risk of illnesses linked to your personal indications and family history.
The patient has a strong family history of cancer involving breast and colorectal cancer from her maternal side.
During the pre-test consultation, our genetic counsellor makes the assessment that his/her family history is compatible with a hereditary predisposition of cancer.
Our physician prescribes a genetic analysis for a targeted panel including the following genes: APC, BMPR1A, BRCA1, BRCA2, CDH1, MLH1, MSH2, MSH6, MUTYH, PALB2, PMS2, PTEN, TP53 which are associated to the hereditary predisposition of breast, ovarian and colorectal cancer.
A pathogenic mutation is found in BRCA1 conferring an 85% risk of developing breast and ovarian cancer, prompting our physician to propose risk-reduction measures including:
These measures allow an appropriate management ultimately decreasing the initial higher risk of developing a cancer to the average normal risk.
The price will depend on the panel of genetic anaylsis that the patient will be advised to do. It starts from CHF 1500.00.